BRCA1‐associated‐protein‐1 inactivated melanocytic tumours: characterisation of the clinicopathological spectrum and immunohistochemical expression pattern of preferentially expressed antigen in melanoma
BIMT are more common in a sporadic setting and behave indolently, despite worrying cytological atypia. PRAME immunohistochemistry is a reassuring tool in distinguishing BIMT from melanoma.
Authors
- Thomas Brenn (ORCID: https://orcid.org/0000-0002-0089-0352)
- Alejandro Ariel Gru (ORCID: https://orcid.org/0000-0002-2573-8074)
- Katharina Wiedemeyer (ORCID: https://orcid.org/0000-0002-0754-2393)
- Yitong Xu (ORCID: https://orcid.org/0009-0009-0872-8024)
Institutions
- NewYork–Presbyterian Hospital (US)
- University of Calgary (CA)
- University of Michigan (US)
- New York Hospital Queens (US)
- University of Virginia (US)
- Columbia University (US)
Publication Details
- Journal
- Histopathology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1111/his.15318
- Citations
- 3
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- University of Calgary